Dhurandhar 2 vs Toxic: US Pre-Sales Show Clear Leader
The highly anticipated release of Dhurandhar 2, starring Ranveer Singh, is setting the stage for a major box office showdown with Yash's Toxic. While domestic buzz in India heavily favors Toxic, the North American market tells a different story, with Dhurandhar 2 emerging as the frontrunner in pre-sales.
Dhurandhar 2's Strong US Performance
In the United States, Dhurandhar 2 has generated significant excitement, building on the success of its first installment. According to recent data from Venky Box Office, the film has achieved advance bookings worth 33.7K USD, with sales surging by 159% in the last 24 hours alone. The number of shows has increased to 209, and over 1.9K tickets have been sold across 151 locations.
With 17 days remaining before its premiere, trade analysts predict that Dhurandhar 2 could close with blockbuster-level pre-sales. The film, featuring an ensemble cast including Sanjay Dutt, Arjun Rampal, and R. Madhavan, is on a strong trajectory despite its clash with Toxic, provided it maintains this momentum.
Toxic's Modest US Growth
On the other hand, Toxic, headlined by Yash, has registered pre-sales of 3.6K USD from 81 US locations. The film's show count has risen to 122, and it witnessed modest growth over the past 24 hours, with approximately 189 tickets sold so far in the American market.
It is important to note that Kannada films are still establishing a consistent overseas presence. However, Yash's return following the blockbuster success of KGF Chapter 2 could provide a significant boost. With 17 days left before release, there is ample time for collections to accelerate.
Record-Breaking Advance Sales
According to a tweet by Venky Box Office, Dhurandhar 2 is maintaining robust momentum 16 days ahead of its release and is eyeing a record-breaking Hindi premiere number. The update revealed that the film earned 67,112 USD through the sale of 3,932 tickets, pushing its total advance sales beyond the 100K USD mark.
For now, Ranveer Singh and his team are clearly leading the North American race. The gap in show count between the two films remains substantial, but industry observers remain hopeful that Geetu Mohandas' directorial venture, Toxic, will gather steam as additional shows are rolled out.
Domestic Box Office Dynamics
Meanwhile, in the domestic Indian market, Toxic may dominate due to its stronger screen presence in southern regions. For example, in Kerala, the Yash starrer has double the number of screens compared to Dhurandhar 2. This regional advantage could play a crucial role in the overall box office outcome, highlighting the contrasting dynamics between domestic and international markets.
As the release date approaches, both films are poised for a fierce competition, with Dhurandhar 2 currently holding the edge in US pre-sales while Toxic leverages its domestic strength.
